Search clinical trials for: Refractory Hodgkin's Lymphoma

Total 16690 results

University Hospital, Bonn

Unknown

Primary Anatomical Versus Primary Electrophysiological Approach in Circumferential Pulmonary Vein Ablation (CPVA-PAF)

Paroxysmal Atrial Fibrillation
Gruppo Italiano Multiregionale per lo studio dei...

Completed

Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma (DLBCL)

Diffuse Large B-Cell Lymphoma | POOR PROGNOSIS

Italy
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; International...

Terminated

Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression (rTMS)

Depression

France
Abbott

Withdrawn

A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma

Asthma
Southwestern Regional Medical Center

Terminated

ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer

Colorectal Neoplasms

United States
Hokkaido Gastrointestinal Cancer Study Group
Hokkaido University Hospital

Suspended

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Metastatic Colorectal Cancer

Japan
French Innovative Leukemia Organisation

Completed

Treatment of Disseminated High Grade Lymphoma

Lymphoma

France
French Innovative Leukemia Organisation

Completed

Treatment of Localized Low Grade Lymphomas

Lymphoma, Low-Grade

France
Gruppo Italiano MEsotelioma

Unknown

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

Mesothelioma

Italy
German AML Cooperative Group

Unknown

Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

Relapsed Acute Promyelocytic Leukemia | Refractory Acute Promyelocytic Leukemia

Germany
Johann Wolfgang Goethe University Hospital

Unknown

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Philadelphia Positive Acute Lymphoblastic Leukemia | Lymphoid Blastic Phase of Chronic Myeloid Leukemia

Germany
Swedish Medical Center
Novartis

Completed

Phase II Trial of RAD001 in Refractory Colorectal Cancer

Colorectal Cancer

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma

Hematologic Neoplasms

United States, Canada
Herlev Hospital
Eli Lilly and Company; Sanofi

Completed

Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer

Prostate Cancer

Denmark
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Adult ALL Treatment at Diagnosis (LAL2000)

Leukemia, Lymphocytic, Acute

Italy
London North West Healthcare NHS Trust

Unknown

Bowel Preparation and Prokinetics in Capsule Endoscopy

Gastrointestinal Hemorrhage | Small Bowel Disease | Refractory Anemia

United Kingdom
Weintraub, Michael I., MD, FACP, FAAN
Dr. Steven P. Cole, PhD. Statistician

Completed

Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome

Refractory Carpal Tunnel Syndrome | Neurpathic Pain | Neuromodulaton

United States
Daiichi Sankyo, Inc.

Completed

Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)

Lymphoma | Malignancies

United States
Cytogen Corporation

Unknown

Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer (CYT-500)

Metastatic Prostate Cancer

United States
National Taiwan University Hospital

Unknown

Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan

Leukemia, Lymphocytic, Acute

Taiwan
Gilead Sciences

Terminated

ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia

Fungal Infection

Germany
Arbeitsgemeinschaft medikamentoese Tumortherapie

No longer available

Dose-Dense Therapy in Aggressive Lymphoma

Lymphoma
Abbott

Completed

Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

Prostatic Neoplasms

Canada, United States, Spain, Belgium, Australia, Italy, United Kingdom, Germany, France, Sweden, South Africa, Netherlands, Ireland, New Zealand, Greece, Poland, Austria
Gachon University Gil Medical Center
Sanofi

Unknown

Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC

Stomach Neoplasm | Recurrent | Stage IV

Korea, Republic of
Sundsvall Hospital

Completed

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

Multiple Myeloma | Anemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

Sweden
Georgetown University

Completed

Urban Environmental Exposures and Childhood Cancer

Acute Lymphoblastic Leukemia | Brain Cancer

United States
Lymphoma Study Association
Fondation ARC

Completed

ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

Lymphoma, Large-Cell, Diffuse

France, Belgium
Christian Medical College, Vellore, India

Unknown

Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease

Graft vs Host Disease

India
Bispebjerg Hospital

Terminated

Study of Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides

Mycosis Fungoides
Lymphoma Study Association

Completed

Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden

Lymphoma

France, Belgium
Ophthalmic Consultants of Boston
Bausch & Lomb Incorporated

Unknown

Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser

Diabetic Macular Edema

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

Ulcerative Colitis

United States
MedImmune LLC

Terminated

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Lymphoma | Leukemia | Cancer

United States
French Innovative Leukemia Organisation

Completed

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Leukemia, Lymphocytic, Acute

France
University of Edinburgh
Pfizer

Completed

Blood Pressure Interaction Between Sildenafil and Sublingual Glyceryl Trinitrate (GTN) in Men With Angina

Angina Pectoris

United Kingdom
Urological Sciences Research Foundation
Allergan

Unknown

This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo. (BTX0621)

Overactive Bladder

United States
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Unknown

A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer

Pancreatic Cancer

Taiwan
University of Sao Paulo

Unknown

Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study) (IBEME)

Diabetic Macular Edema

Brazil
Hospices Civils de Lyon

Unknown

Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study (TEPELY)

Lymphoma

France
Hospices Civils de Lyon

Unknown

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.

Acute Lymphocytic Leukemia

France
Hospices Civils de Lyon

Unknown

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Chronic Myeloid Leukemia

France
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center

Completed

Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

Lymphoma | Multiple Myeloma | Acute Myelogenous Leukemia

United States
University Health Network, Toronto

Completed

Dose Reduction in Thoracic CT

Lymphoma

Canada
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Leukemia | Hairy Cell Leukemia | HCL

United States, Poland, United Kingdom
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Leukemia

United States, Poland
ViaCell

Completed

Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers

Acute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Chronic Myelogenous Leukemia

United States
Children's Mercy Hospital Kansas City

Completed

Osteoporosis in Children With ALL

Leukemia, Lymphocytic, Acute, L1

United States
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Unknown

a Phase II Study in Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma

Taiwan
Latin American Cooperative Onco-Haematology Group...

Unknown

Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome

Mycosis Fungoides | Sezary Syndrome

Peru
University of Salamanca
Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo...

Unknown

Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell

Graft-vs-Host Disease (GVHD)

Spain

Search clinical trials for: Refractory Hodgkin's Lymphoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations